Skip to main content

About LAVVAN

Industry pioneers. Revolutionizing cannabinoids (again).

LAVVAN is reimagining the cannabinoid production process to deliver high-quality, reliably sourced and cost-competitive cannabinoid ingredients

Company Overview

LAVVAN produces a range of natural cannabinoid ingredients using its advanced cellular agriculture platform which supplies cannabinoids with unparalleled purity, consistency, potency and sustainability to serve a range of industries including health, beauty, food and beverage and pharmaceuticals.

LAVVAN is led by one of the most influential, respected and pioneering teams in the global cannabis industry. After the $2.5 billion purchase of MedReleaf Corp. – a company that from 2014 to 2018 was one of the largest legal producers of cannabinoids in the world – the team dedicated itself to once again revolutionizing the industry that it helped to birth, by bringing to it a level of quality, reliability and sustainability that global brands, manufacturers and suppliers can depend on.

Neil Closner

Neil Closner

Chief Executive Officer

Etan Bendheim

Etan Bendheim

President

Dr Jeremy Friedberg

Dr. Jeremy N. Friedberg

Chief Science Officer

Angelo Fefekos

Angelo Fefekos

SVP, Regulatory Affairs & Quality Assurance

Adam Noyek

Adam Noyek

SVP, Operations

Daniel Goldberg

Daniel Goldberg

SVP, Corporate Development

Jason Fleming

Jason Fleming, CHRE

VP, Human Resources

Umar Syed

Umar Syed

Senior Advisor, Product Strategy

Alexia Blake

Alexia Blake

Director, Product Development

Istok Nahtigal

Istok Nahtigal

Director, Process Sciences

Ori Sher

Ori Sher

VP, Infrastructure & Security

 

Request Submitted
Thank you for your interest in LAVVAN!

A representative will contact you shortly.

Return To Page

Talk to Us